SCHEMBL6823630

SCHEMBL6823630

Cc1ccc(C(=O)c2ccc(O)c(-c3cc(N4CC4)nc(N)n3)c2)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 5/20 0.49
CDK2 P24941 5/20 0.49
HSD17B14 Q9BPX1 1/20 0.38
HRH4 Q9H3N8 4/20 0.37
HTR3A P46098 1/20 0.37
RAF1 P04049 1/20 0.37
BRAF P15056 1/20 0.37
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2C P18825 1/20 0.36
HTR1D P28221 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR7 P34969 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6918875 0.96 CDK1 (0.55) CDK1CDK2HSD17B14HRH4HTR3A
SCHEMBL6826440 0.94 CDK1 (0.55) CDK1CDK2RAF1BRAF
SCHEMBL6825113 0.94 CDK1 (0.44) CDK1CDK2HRH4RAF1BRAF
SCHEMBL6820798 0.87 CDK1 (0.40) CDK1CDK2HSD17B14HRH4RAF1
SCHEMBL6826342 0.84 KMT2A (0.40) CDK1CDK2HSD17B14
SCHEMBL6824426 0.82 CDK1 (0.43) CDK1CDK2HSD17B14HRH4
SCHEMBL6824603 0.82 MAPT (0.39) CDK1CDK2HSD17B14
SCHEMBL6823658 0.82 HSD17B14 (0.36) CDK1CDK2HSD17B14
SCHEMBL7064551 0.82 ADORA2A (0.41) CDK1CDK2HSD17B14HRH4
SCHEMBL6824582 0.81 CYP46A1 (0.39) CDK1CDK2HSD17B14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004080979-A1 NOVEL 3-(2-AMINO-4-PYRIMIDINYL)-4-HYDROXYPHENYL KETONE DERIVATIVES LG LIFE SCIENCES LTD. (KR) 2004-09-23 WO claimed
WO-2004080979-A1 NOVEL 3-(2-AMINO-4-PYRIMIDINYL)-4-HYDROXYPHENYL KETONE DERIVATIVES LG LIFE SCIENCES LTD. (KR) 2004-09-23 WO disclosed